Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 28, 2020

SELL
$4.78 - $8.26 $101,140 - $174,773
-21,159 Closed
0 $0
Q1 2020

Apr 28, 2020

BUY
$4.0 - $21.53 $4,000 - $21,530
1,000 Added 4.96%
21,159 $85,000
Q4 2018

Feb 12, 2019

BUY
$12.41 - $22.98 $126,073 - $233,453
10,159 Added 101.59%
20,159 $274,000
Q3 2017

Oct 24, 2017

BUY
$3.03 - $3.72 $30,299 - $37,200
10,000
10,000 $35,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $242M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Youngs Advisory Group, Inc. Portfolio

Follow Youngs Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Youngs Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Youngs Advisory Group, Inc. with notifications on news.